TY - JOUR
T1 - Effects of polyenylphosphatidylcholine on cytokines, nitrite/nitrate levels, antioxidant activity and lipid peroxidation in rats with sepsis
AU - Demirbilek, Semra
AU - Ersoy, Mehmet Özcan
AU - Demirbilek, Savaş
AU - Karaman, Abdurrahman
AU - Akın, Melih
AU - Bayraktar, Mehmet
AU - Bayraktar, Nihayet
PY - 2004/10
Y1 - 2004/10
N2 - Objectives: To determine the effect of pretreatment with polyenylphosphatidylcholine (lecithin, PPC) on plasma levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, total nitrite/nitrate (NOx), and tissue levels of superoxide dismutase (SOD) and malondialdehyde (MDA) in septic rats. Design: Prospective, randomized, controlled animal study. Setting: University laboratory. Subjects: Forty-five Spraque-Dawley rats were divided into three groups: group C, sham-operated; group S, sepsis; and group P, sepsis pretreated with PPC. Interventions: Rats were made septic by cecal ligation and puncture (CLP). Group P rats were treated with PPC (100 mg/day orally) for 10 days before sepsis. Twenty-four hours later CLP, plasma concentrations of TNF-α, IL-6 and IL-10 and plasma levels of NOx were measured. SOD and MDA were determined in liver, lung and heart homogenates. Measurements and main results: All rats in group P survived during the 24-h observation time after CLP, whereas survival rate in group S was 66.7% (10/15; P<0.05). PPC significantly reduced plasma levels of TNF-α (P=0.006), IL-6 (P=0.007), IL-10 (P=0.016), NOx (P<0.001), and tissue levels of MDA (P<0.001) in group P with respect to in group S. Tissue levels of SOD significantly increased in group P when compared with group S (P<0.001). Conclusions: These results show that PPC pretreatment exerts cumulative effects in decreasing the levels of cytokines, NOx, and tissue MDA concentrations, with a concomitant increase in survival in septic rats. Lecithin therapy may be a useful adjuvant therapy in controlling of the excessive production of the inflammatory cytokines in patients with severe sepsis. Descriptor: SIRS/sepsis, experimental studies.
AB - Objectives: To determine the effect of pretreatment with polyenylphosphatidylcholine (lecithin, PPC) on plasma levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-10, total nitrite/nitrate (NOx), and tissue levels of superoxide dismutase (SOD) and malondialdehyde (MDA) in septic rats. Design: Prospective, randomized, controlled animal study. Setting: University laboratory. Subjects: Forty-five Spraque-Dawley rats were divided into three groups: group C, sham-operated; group S, sepsis; and group P, sepsis pretreated with PPC. Interventions: Rats were made septic by cecal ligation and puncture (CLP). Group P rats were treated with PPC (100 mg/day orally) for 10 days before sepsis. Twenty-four hours later CLP, plasma concentrations of TNF-α, IL-6 and IL-10 and plasma levels of NOx were measured. SOD and MDA were determined in liver, lung and heart homogenates. Measurements and main results: All rats in group P survived during the 24-h observation time after CLP, whereas survival rate in group S was 66.7% (10/15; P<0.05). PPC significantly reduced plasma levels of TNF-α (P=0.006), IL-6 (P=0.007), IL-10 (P=0.016), NOx (P<0.001), and tissue levels of MDA (P<0.001) in group P with respect to in group S. Tissue levels of SOD significantly increased in group P when compared with group S (P<0.001). Conclusions: These results show that PPC pretreatment exerts cumulative effects in decreasing the levels of cytokines, NOx, and tissue MDA concentrations, with a concomitant increase in survival in septic rats. Lecithin therapy may be a useful adjuvant therapy in controlling of the excessive production of the inflammatory cytokines in patients with severe sepsis. Descriptor: SIRS/sepsis, experimental studies.
KW - Cytokines
KW - Lipid peroxidation
KW - NO
KW - Oxidative stress
KW - Polyenylphosphatidylcholine
KW - Sepsis
UR - http://www.scopus.com/inward/record.url?scp=7944226551&partnerID=8YFLogxK
U2 - 10.1007/s00134-004-2234-4
DO - 10.1007/s00134-004-2234-4
M3 - Article
C2 - 15045164
AN - SCOPUS:7944226551
SN - 0342-4642
VL - 30
SP - 1974
EP - 1978
JO - Intensive Care Medicine
JF - Intensive Care Medicine
IS - 10
ER -